| 000 | 01692 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517061921.0 | ||
| 264 | 0 | _c20160205 | |
| 008 | 201602s 0 0 eng d | ||
| 022 | _a1532-1827 | ||
| 024 | 7 |
_a10.1038/bjc.2015.305 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRoos, Alison | |
| 245 | 0 | 0 |
_aLoss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cNov 2015 |
||
| 300 |
_a1289-97 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCaspase 3 _xgenetics |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCore Binding Factor Alpha 1 Subunit _xgenetics |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aOsteosarcoma _xdrug therapy |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-myc _xgenetics |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
| 650 | 0 | 4 |
_aTranscriptional Activation _xdrug effects |
| 700 | 1 | _aSatterfield, Laura | |
| 700 | 1 | _aZhao, Shuying | |
| 700 | 1 | _aFuja, Daniel | |
| 700 | 1 | _aShuck, Ryan | |
| 700 | 1 | _aHicks, M John | |
| 700 | 1 | _aDonehower, Lawrence A | |
| 700 | 1 | _aYustein, Jason T | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 113 _gno. 9 _gp. 1289-97 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/bjc.2015.305 _zAvailable from publisher's website |
| 999 |
_c25413816 _d25413816 |
||